Glassman has always been a fighter, an us-versus-them kind of guy, and as his company has grown, so has his arsenal: CrossFit now has seven lawyers on staff and at any given time is engaging 12 to 20 outside legal firms to pursue trademark-infringement cases. CrossFit has a database of more than 5,000 possible infringements and is litigating a dozen lawsuits in the U.S. and several more internationally.
Former athletes – CrossFit has built-in teamwork, camaraderie, and competition. Almost all workouts have a time component to them, where you either have to finish a certain number of repetitions of exercises in a certain amount of time, or the time is fixed and you need to see how many repetitions you can do of an exercise. You get to compete with people in your class, and go online to see how you did against the world’s elite CrossFit athletes. There is even an international competition for those that become truly dedicated.
The "CrossFit Games", directed by Dave Castro, have been held every summer since 2007. Athletes at the Games compete in workouts they learn about only hours beforehand, sometimes including surprise elements that are not part of the typical CrossFit regimen. Past examples include a rough-water swim, a softball throw, and a pegboard climb. The Games are styled as a venue for determining the "Fittest on Earth," where competitors should be "ready for anything."
On Day 4, I reached for a beef jerky stick from Epic. I simultaneously took a big bite while turning over the packaging to read the label. When I saw it on the ingredients list, I stopped mid-chew: "honey." I immediately spit the partially chewed jerky in my garbage can. Close one. After that, I always read the labels on my food twice before eating a morsel.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”